RE:RE:Loading up?It likely includes TH building their inventories of IV Push. But Bloomberg's weekly sales estimator also suggests the introduction of IV Push had a positive impact on October's Trogarzo sales. Not that positive but a nice percentage increase. Unfortunately, Bloomberg's estimates have been dubious in the past so it could be better or worse than how it appears.
qwerty22 wrote: Hard to see it being actual drug sales to patients. Some other revenue realized. Say selling THTX shares. Can that be classed as revenue from Trogarzo?